route
The path by which the vaccine product is taken into the body.
A SNOMED CT concept ID value from either of the following SHOULD be used:
UK “ePrescribing route of administration simple reference set (foundation metadata concept)” (999000051000001100) ValueSet UKCore-SubstanceOrProductAdministrationRoute
or:
UK published reference set “Vaccine route of administration simple reference set” (115231000001104).
Immunization.id[0] | UKCore-Immunization-Sn-IntramuscularRoute-Example |
Immunization.meta[0].profile[0] | https://fhir.hl7.org.uk/StructureDefinition/UKCore-Immunization |
Immunization.status[0] | completed |
Immunization.vaccineCode[0].coding[0].system[0] | https://dmd.nhs.uk |
Immunization.vaccineCode[0].coding[0].code[0] | 39114911000001105 |
Immunization.vaccineCode[0].coding[0].display[0] | COVID-19 Vaccine Vaxzevria (ChAdOx1 S [recombinant]) not less than 2.5x100,000,000 infectious units/0.5ml dose suspension for injection multidose vials (AstraZeneca UK Ltd) |
Immunization.patient[0].reference[0] | Patient/UKCore-Patient-RichardSmith-Example |
Immunization.occurrenceDateTime[0] | 2021-07-20 |
Immunization.route[0].coding[0].system[0] | http://snomed.info/sct |
Immunization.route[0].coding[0].code[0] | 78421000 |
Immunization.route[0].coding[0].display[0] | Intramuscular route (qualifier value) |
Immunization |
id : UKCore-Immunization-Sn-IntramuscularRoute-Example |
meta |
profile : https://fhir.hl7.org.uk/StructureDefinition/UKCore-Immunization |
status : completed |
vaccineCode |
coding |
system : https://dmd.nhs.uk |
code : 39114911000001105 |
display : COVID-19 Vaccine Vaxzevria (ChAdOx1 S [recombinant]) not less than 2.5x100,000,000 infectious units/0.5ml dose suspension for injection multidose vials (AstraZeneca UK Ltd) |
patient |
reference : Patient/UKCore-Patient-RichardSmith-Example |
occurrence : 2021-07-20 |
route |
coding |
system : http://snomed.info/sct |
code : 78421000 |
display : Intramuscular route (qualifier value) |
<Immunization xmlns="http://hl7.org/fhir"> <id value="UKCore-Immunization-Sn-IntramuscularRoute-Example" /> <meta> <profile value="https://fhir.hl7.org.uk/StructureDefinition/UKCore-Immunization" /> </meta> <status value="completed" /> <vaccineCode> <coding> <system value="https://dmd.nhs.uk" /> <code value="39114911000001105" /> <display value="COVID-19 Vaccine Vaxzevria (ChAdOx1 S [recombinant]) not less than 2.5x100,000,000 infectious units/0.5ml dose suspension for injection multidose vials (AstraZeneca UK Ltd)" /> </coding> </vaccineCode> <patient> <reference value="Patient/UKCore-Patient-RichardSmith-Example" /> </patient> <occurrenceDateTime value="2021-07-20" /> <!-- **************snippet start************** --> <route> <coding> <system value="http://snomed.info/sct" /> <code value="78421000" /> <display value="Intramuscular route (qualifier value)" /> </coding> </route> <!-- **************snippet end************** --> </Immunization>
{ "resourceType": "Immunization", "id": "UKCore-Immunization-Sn-IntramuscularRoute-Example", "meta": { "profile": [ "https://fhir.hl7.org.uk/StructureDefinition/UKCore-Immunization" ] }, "status": "completed", "vaccineCode": { "coding": [ { "system": "https://dmd.nhs.uk", "code": "39114911000001105", "display": "COVID-19 Vaccine Vaxzevria (ChAdOx1 S [recombinant]) not less than 2.5x100,000,000 infectious units/0.5ml dose suspension for injection multidose vials (AstraZeneca UK Ltd)" } ] }, "patient": { "reference": "Patient/UKCore-Patient-RichardSmith-Example" }, "occurrenceDateTime": "2021-07-20", "route": { "coding": [ { "system": "http://snomed.info/sct", "code": "78421000", "display": "Intramuscular route (qualifier value)" } ] } }